A208370 Stock Overview
SELVAS Healthcare, Inc. manufactures and sells medical diagnostic devices and visual aids products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
SELVAS Healthcare, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩4,745.00 |
| 52 Week High | ₩13,090.00 |
| 52 Week Low | ₩4,525.00 |
| Beta | -0.0091 |
| 1 Month Change | -18.19% |
| 3 Month Change | -28.00% |
| 1 Year Change | -32.89% |
| 3 Year Change | 68.26% |
| 5 Year Change | 102.35% |
| Change since IPO | -61.58% |
Recent News & Updates
Recent updates
Investors Shouldn't Be Too Comfortable With SELVAS Healthcare's (KOSDAQ:208370) Earnings
Mar 27
Is SELVAS Healthcare (KOSDAQ:208370) Using Too Much Debt?
Mar 11SELVAS Healthcare's (KOSDAQ:208370) Stock Price Has Reduced 62% In The Past Three Years
Jan 26
What Do The Returns At SELVAS Healthcare (KOSDAQ:208370) Mean Going Forward?
Jan 03We Wouldn't Rely On SELVAS Healthcare's (KOSDAQ:208370) Statutory Earnings As A Guide
Dec 08Shareholder Returns
| A208370 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -0.5% | 7.6% | 3.4% |
| 1Y | -32.9% | 33.4% | 7.1% |
Price Volatility
| A208370 volatility | |
|---|---|
| A208370 Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 110 | Chul-Joong Kwon | www.selvashealthcare.com |
SELVAS Healthcare, Inc. manufactures and sells medical diagnostic devices and visual aids products. The company develops, manufactures, and sells body composition analyzers and automatic blood pressure monitors. It provides rehabilitation medical auxiliary equipment under HIMS brand name, as well as provides health solution under ACCUNIQ brand name.
SELVAS Healthcare, Inc. Fundamentals Summary
| A208370 fundamental statistics | |
|---|---|
| Market cap | ₩121.75b |
| Earnings (TTM) | ₩5.17b |
| Revenue (TTM) | ₩29.81b |
23.5x
P/E Ratio4.1x
P/S RatioIs A208370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A208370 income statement (TTM) | |
|---|---|
| Revenue | ₩29.81b |
| Cost of Revenue | ₩14.30b |
| Gross Profit | ₩15.51b |
| Other Expenses | ₩10.34b |
| Earnings | ₩5.17b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 201.49 |
| Gross Margin | 52.04% |
| Net Profit Margin | 17.34% |
| Debt/Equity Ratio | 4.8% |
How did A208370 perform over the long term?
See historical performance and comparison